Replies to post #159284 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

Yes but you are bringing additional value to the table in this case that Direct will be continued by NWBO. If NWBO announces the start date of continuing the trial after L is approved, then that changes the valuation of NWBO immediately I agree. But the debate (SOS) was ONLY and just ONLY L no new trials nothing just L. No royalties, buy out, etc ONLY L is $ 4-5 per share IF 1 billion shares IMO and that is even pushing it. However, unfortunately, NWBO will dilute another 50-100 million shares is my estimate until topline. all IMO